Blister-reaction after the administration of interleukin-2 [4];Reacción ampollar tras la administración de interleucina 2

Medicina Clinica

Volumn 123, Issue 16, 2004, Pages 637-

  Brun Romero, Francisco Manuel ^a   Terrón Pernía, José Alberto ^a  

^a HOSPITAL DE JEREZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; INTERLEUKIN 2; PARACETAMOL;

ADULT; BLISTER; CASE REPORT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION SITE; LETTER;

EID: 19744366505     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13068445     Document Type: Letter

References (7)

1. Katlama C, Carcelain G, Duvivier C, Chouquet C, Tubiana R, De Sa M, et al. Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study-ANRS 082. AIDS 2002;16:2027-34.
2. Marchetti G, Meroni L, Varchetta S, Terzieva V, Bandera A, Manganaro D, et al. Low-dose prolonged intermittent Interleukin-2 adjuvant therapy: results of a randomised trial among Human Immunodeficiency Virus-positive patients with advanced immune impairment. J Infect Dis 2002; 186:606-16.
3. Paredes R, López JC, Fernândez-Cruz E, Clotet B, Clifford H. The potential role of interleukin-2 in patients with HIV infection. AIDS Rev 2002;4:36-40.
4. Davey R, Murphy R, Graziano F, Boswell SL, Pavia AT, Cancio M, et al. Immunologic and virologic effects of subcutaneous interleukin-2 in combination with antiretroviral therapy. JAMA 2000;284: 183-9.
5. Arnó A, Ruiz L, Juan M, Jou A, Balagué M, Zayat MK, et al. Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with < 250/μl CD4 T cells and undetectable plasma virus load. J Infect Dis 1999;180:56-60.
6. Kovacs J, Vogel S, Albert J, Falloon J, Davey RT Jr, Walker RE, et al. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl J Med 1996; 335:1350-6.
7. Resino S, Bellón JM, Jiménez JL, Gurbindo MD, Muñoz-Fernández. Papel de las citocinas y las quimiocinas en la no-progresión de la infección por VIH-1 en niños infectados verticalmente. Med Clin (Barc) 2000;114:641-6.